Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Viridian Therapeutics, Inc.\DEListing on record | AwardD (derivative) | $40M | SEC | ||
Viridian Therapeutics, Inc.\DEListing on record | Buy | $10M | conv 46First in 12mo | SEC | |
MedGen, Inc.Listing unverified | BuyD (derivative) | $13.4M | First in 12mo | SEC | |
MedGen, Inc.Listing unverified | BuyD (derivative) | $2.6M | First in 12mo | SEC |